"A few AEFI cases were reported but most were minor and the persons were normalised during observation period. Only one severe AEFI case was reported in South Delhi," said a top government official.
According to World Health Organisation (WHO), any untoward medical occurrence which follows immunisation and does not necessarily have a causal relationship with the usage of the vaccine, is known as AEFI.
District officials said most of the persons who developed "minor" AEFI post vaccination complained about dizziness and headache. They will be monitored for a few days to ensure their normal state of health, they said.
In AIIMS here, a security guard who was administered a shot of Covaxin on Saturday was admitted at the hospital after he developed an allergic reaction as part of "severe" adverse events following immunisation.
According to All India Institute of Medical Sciences Director Randeep Guleria, the security guard, in his 20s, at AIIMS who received the jab after 4 pm, complained of palpitations and developed an allergic skin rash within 15-20 minutes after being inoculated and was admitted to the facility.
Eleven cases of "minor" AEFI were reported from south and southwest districts, showed official data.
The "minor" AEFI cases were reported from all districts except northeast and Shahdara districts, officials said.
Administration of coronavirus vaccine started in Delhi at 81 centres across the city on Saturday. Each Centre was targeted to administer vaccines to 100 people (health workers).
Northwest and west Delhi districts had the highest target of 1,100 vaccinations each where 706 and 487 people, respectively, were vaccinated.
In northeast Delhi, there were two vaccination centres and a total of 77 people were vaccinated against the target of 200 people, official figures showed.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.